[Synthesis bulletin of 2005 surveillance. Clinical practice recommendations: the use of PET-FDG in cancers of the breast, ovary and uterus]

Bull Cancer. 2006 Apr;93(4):385-90.

[Article in French]

Authors

P Bourguet¹, A Hitzel, G Houvenaeghel, D Vinatier, L Bosquet, F Bonichon, C Corone, S Giard-Lefèvre, J-L Morett, E Touboul; Standards Options et Recommandations; Institut National du Cancer; Fédération Nationale des Centres de Lutte contre le Cancer; Ligue Nationale contre le Cancer; SFMN; Fédération Hospitalière de France; Fédération Nationale de Cancérologie des CHRU; Fédération Française de Cancérologie

Affiliation

¹ Médecin nucléaire, Centre Eugène-Marquis, Rennes.

PMID: 16714228

No abstract available

Publication types

Practice Guideline

MeSH terms

Breast Neoplasms / diagnostic imaging*
Female
Fluorodeoxyglucose F18*
Humans
Ovarian Neoplasms / diagnostic imaging*
Positron-Emission Tomography / standards*
Radiopharmaceuticals*
Uterine Neoplasms / diagnostic imaging*

Substances

Radiopharmaceuticals
Fluorodeoxyglucose F18